Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation
Authors
Keywords
-
Journal
Cell Discovery
Volume 3, Issue -, Pages 17010
Publisher
Springer Nature
Online
2017-04-19
DOI
10.1038/celldisc.2017.10
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- TGF-β Tumor Suppression through a Lethal EMT
- (2016) Charles J. David et al. CELL
- Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer
- (2016) Reema Wahdan-Alaswad et al. CELL CYCLE
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Mifepristone Suppresses Basal Triple-Negative Breast Cancer Stem Cells by Down-regulating KLF5 Expression
- (2016) Rong Liu et al. Theranostics
- Metformin in Cancer Treatment and Prevention
- (2015) Daniel R. Morales et al. Annual Review of Medicine
- Metformin synergizes 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) combination therapy through impairing intracellular ATP production and DNA repair in breast cancer stem cells
- (2015) Jaslyn Sian-Siu Soo et al. APOPTOSIS
- Generation and characterization of a breast carcinoma model by PyMT overexpression in mammary epithelial cells of tree shrew, an animal close to primates in evolution
- (2015) Guang-Zhe Ge et al. INTERNATIONAL JOURNAL OF CANCER
- Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
- (2015) Devon A. Lawson et al. NATURE
- KLF5 promotes breast cancer proliferation, migration and invasion in part by upregulating the transcription of TNFAIP2
- (2015) L Jia et al. ONCOGENE
- Metformin—mode of action and clinical implications for diabetes and cancer
- (2014) Ida Pernicova et al. Nature Reviews Endocrinology
- TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells
- (2014) M Bartucci et al. ONCOGENE
- PKA signaling drives mammary tumorigenesis through Src
- (2014) A G Beristain et al. ONCOGENE
- Metformin-Induced Killing of Triple-Negative Breast Cancer Cells Is Mediated by Reduction in Fatty Acid Synthase via miRNA-193b
- (2014) Reema S. Wahdan-Alaswad et al. Hormones & Cancer
- Glucose promotes breast cancer aggression and reduces metformin efficacy
- (2013) Reema Wahdan-Alaswad et al. CELL CYCLE
- Reprogramming Metabolism with Metformin Improves Tumor Oxygenation and Radiotherapy Response
- (2013) V. E. Zannella et al. CLINICAL CANCER RESEARCH
- Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
- (2013) Russell A. Miller et al. NATURE
- Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth
- (2013) H. A. Hirsch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- YAP Promotes Breast Cell Proliferation and Survival Partially through Stabilizing the KLF5 Transcription Factor
- (2012) Xu Zhi et al. AMERICAN JOURNAL OF PATHOLOGY
- Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers
- (2012) Xin-Sheng Deng et al. CELL CYCLE
- Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer
- (2011) Soley Bayraktar et al. CANCER
- Loss of Transcription Factor KLF5 in the Context of p53 Ablation Drives Invasive Progression of Human Squamous Cell Cancer
- (2011) Y. Yang et al. CANCER RESEARCH
- Metformin induces unique biological and molecular responses in triple negative breast cancer cells
- (2011) Bolin Liu et al. CELL CYCLE
- Interactions between cancer stem cells and their niche govern metastatic colonization
- (2011) Ilaria Malanchi et al. NATURE
- The Fbw7 Tumor Suppressor Targets KLF5 for Ubiquitin-Mediated Degradation and Suppresses Breast Cell Proliferation
- (2010) Dong Zhao et al. CANCER RESEARCH
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases
- (2009) Jin-Tang Dong et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- KLF5 Promotes Breast Cell Survival Partially through Fibroblast Growth Factor-binding Protein 1-pERK-mediated Dual Specificity MKP-1 Protein Phosphorylation and Stabilization
- (2009) Rong Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
- (2009) Sao Jiralerspong et al. JOURNAL OF CLINICAL ONCOLOGY
- Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1
- (2009) H -Q Zheng et al. ONCOGENE
- Klf5 is involved in self-renewal of mouse embryonic stem cells
- (2008) S. Parisi et al. JOURNAL OF CELL SCIENCE
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
- (2008) Ittai Ben-Porath et al. NATURE GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started